Bowhead Specialty’s (BOW) Market Perform Rating Reaffirmed at Citizens Jmp

Bowhead Specialty (NYSE:BOW)‘s stock had its “market perform” rating reissued by investment analysts at Citizens Jmp in a research report issued on Thursday, Benzinga reports.

Other equities research analysts have also recently issued reports about the company. Citigroup cut Bowhead Specialty to a “market perform” rating in a research report on Thursday. Morgan Stanley boosted their target price on Bowhead Specialty from $30.00 to $34.00 and gave the stock an “equal weight” rating in a research report on Wednesday, August 19th. Deutsche Bank Aktiengesellschaft downgraded shares of Bowhead Specialty from a “buy” rating to a “hold” rating and set a $34.00 price target on the stock. in a report on Monday, August 3rd. JPMorgan Chase & Co. lifted their price target on shares of Bowhead Specialty from $30.00 to $33.00 and gave the stock a “neutral” rating in a research note on Monday, July 20th. Finally, Piper Sandler cut shares of Bowhead Specialty from an “overweight” rating to a “hold” rating and set a $34.00 price objective for the company. in a report on Monday, August 3rd. One research analyst has rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $33.50.

Bowhead Specialty Stock Performance

Shares of BOW opened at $33.65 on Thursday. The business’s fifty day simple moving average is $32.46 and its two-hundred day simple moving average is $27.82. The company has a current ratio of 0.49, a quick ratio of 0.49 and a debt-to-equity ratio of 0.31. Bowhead Specialty has a 12 month low of $21.21 and a 12 month high of $35.07. The company has a market cap of $1.11 billion, a price-to-earnings ratio of 18.19, a P/E/G ratio of 0.99 and a beta of -0.08.

Bowhead Specialty (NYSE:BOW) last posted its earnings results on Monday, August 3rd. The company reported $0.48 EPS for the quarter, topping analysts’ consensus estimates of $0.47 by $0.01. Bowhead Specialty had a return on equity of 14.05% and a net margin of 10.11%.The business had revenue of $163.86 million during the quarter, compared to analyst estimates of $278.69 million. Research analysts anticipate that Bowhead Specialty will post 2 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Bowhead Specialty

Hedge funds and other institutional investors have recently modified their holdings of the stock. Martingale Asset Management L P raised its holdings in Bowhead Specialty by 1.9% in the 4th quarter. Martingale Asset Management L P now owns 25,791 shares of the company’s stock worth $736,000 after purchasing an additional 484 shares during the period. Invesco Ltd. grew its holdings in Bowhead Specialty by 3.5% during the fourth quarter. Invesco Ltd. now owns 14,484 shares of the company’s stock valued at $413,000 after purchasing an additional 490 shares during the period. Royal Bank of Canada grew its holdings in Bowhead Specialty by 45.5% during the fourth quarter. Royal Bank of Canada now owns 2,065 shares of the company’s stock valued at $59,000 after purchasing an additional 646 shares during the period. Jump Financial LLC increased its position in Bowhead Specialty by 6.6% in the fourth quarter. Jump Financial LLC now owns 10,860 shares of the company’s stock worth $310,000 after buying an additional 673 shares in the last quarter. Finally, Versant Capital Management Inc increased its position in Bowhead Specialty by 262.6% in the second quarter. Versant Capital Management Inc now owns 1,037 shares of the company’s stock worth $31,000 after buying an additional 751 shares in the last quarter.

Bowhead Specialty Company Profile

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.